ArticleMolecular psychiatry2022

Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders.

Shengtao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.